BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6973483)

  • 1. Heterogeneity of cell surface receptors and mitogen reactivity of individual spontaneous AKR lymphomas.
    Nell LJ; Richie ER
    Exp Hematol; 1981 Jul; 9(6):611-8. PubMed ID: 6973483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHA reactivity of spontaneous AKR lymphomas: absolute macrophage requirement.
    Alonso MC; Solana R; Torres A; de la Fuente M; Peña J
    Allergol Immunopathol (Madr); 1984; 12(5):363-7. PubMed ID: 6335356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lymphoma grafts on natural killer cell activity in AKR and C57BL/6 mice.
    Vaillier D; Labat V; Legrand E; Duplan JF
    Nat Immun Cell Growth Regul; 1986; 5(1):41-9. PubMed ID: 3084955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple occurrence of spontaneous AKR/J lymphomas with T and B cell characteristics.
    Greenberg RS; Mathieson BJ; Campbell PS; Zatz MM
    J Immunol; 1977 Apr; 118(4):1181-90. PubMed ID: 300401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of lymphoma in the thymus of AKR mice treated with the lymphomagenic virus SL 3-3.
    Hays EF; Bristol GC; McDougall S; Klotz JL; Kronenberg M
    Cancer Res; 1989 Aug; 49(15):4225-30. PubMed ID: 2545338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface antigen phenotypes of MCF-induced thymic lymphomas in AKR mice.
    Yetter RA; Morse HC
    J Immunol; 1984 May; 132(5):2644-8. PubMed ID: 6609203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
    Rosner A; Peled A; Haran-Ghera N; Canaani E
    Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of membrane immunoglobulin, Ia, and H-2 molecules of thy 1+ AKR/J lymphomas.
    Schwartz BD; Campbell PS; Asofsky R; Greenberg RS; Zatz MM
    J Immunol; 1977 Nov; 119(5):1706-10. PubMed ID: 410882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic drift and clonal variation in differentiation antigen expression on AKR T-cell lymphoma lines grown in vitro.
    Howell AL; Richie ER
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):143-54. PubMed ID: 6150437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomagenesis in AKR.Fv-1b congenic mice.
    Haran-Ghera N; Peled A; Brightman BK; Fan H
    Cancer Res; 1993 Jul; 53(14):3433-8. PubMed ID: 8324753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline malignant lymphomas: comparison of morphologic and immunologic characteristics.
    Holmberg CA; Manning JS; Osburn BI
    Am J Vet Res; 1976 Dec; 37(12):1455-60. PubMed ID: 793460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of RFM mouse T lymphocyte anti-oncofetal antigen immunity in apparent tumor-free, long-term survivors of sublethal X-irradiation by limiting dilution T lymphocyte cloning.
    Rohrer JW; Culpepper C; Barsoum AL; Coggin JH
    J Immunol; 1995 Mar; 154(5):2266-80. PubMed ID: 7868899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenetics of a thymus antigen in lymphoma-prone and lymphoma-resistant colonies of wild mice.
    Blankenhorn EP; Gardner MB; Estes JD
    J Natl Cancer Inst; 1975 Mar; 54(3):665-72. PubMed ID: 1079056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and characterization of two component tumor lines within the AKR lymphoma, AKTB-1, by fluorescence-activated cell sorting and flow microfluorometry analysis. I. the coexistence of sIg+ and sIg- sublines.
    Zatz MM; Mathieson BJ; Kanellopoulos-Langevin C; Sharrow SO
    J Immunol; 1981 Feb; 126(2):608-13. PubMed ID: 6969755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of passive anti-viral immunotherapy in AKR mice: II. Susceptibility to B cell lymphomagenesis.
    Haran-Ghera N; Peled A; Canaani E; Caspi Y; Haimovich J; Shaft D; Resnitzky P; Brightman BK; Fan H
    Leukemia; 1995 Nov; 9(11):1940-7. PubMed ID: 7475287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals.
    Mardiney M; Brown MR; Fleisher TA
    Cytometry; 1996 Dec; 26(4):305-10. PubMed ID: 8979031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analyses of the rearrangement of T-cell receptor- and immunoglobulin genes in the diagnosis of lymphoproliferative disorders].
    Griesser DH
    Veroff Pathol; 1995; 144():1-109. PubMed ID: 7856305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and classification of rat leukemias and lymphomas by membrane markers.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 May; 41(5):1938-42. PubMed ID: 6111394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.
    Copie-Bergman C; Plonquet A; Alonso MA; Boulland ML; Marquet J; Divine M; Möller P; Leroy K; Gaulard P
    Mod Pathol; 2002 Nov; 15(11):1172-80. PubMed ID: 12429796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a monoclonal antibody recognizing an epitope designated as canine leukocyte-associated antigen.
    Yang WC; Esquenazi V; Carreno M; Vallone T; Fuller L; Roth D; Nery J; Burke G; Miller J
    Transplantation; 1994 Jul; 58(2):233-40. PubMed ID: 7518977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.